Kahira Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 5/6
Kahira Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP832.5M and total debt of EGP200.0M, which brings its debt-to-equity ratio to 24%. Its total assets and total liabilities are EGP1.5B and EGP682.6M respectively. Kahira Pharmaceuticals & Chemical Industries's EBIT is EGP285.7M making its interest coverage ratio 67. It has cash and short-term investments of EGP168.3M.
Key information
24.0%
Debt to equity ratio
ج.م200.00m
Debt
| Interest coverage ratio | 67x |
| Cash | ج.م168.28m |
| Equity | ج.م832.49m |
| Total liabilities | ج.م682.60m |
| Total assets | ج.م1.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPCI's short term assets (EGP1.1B) exceed its short term liabilities (EGP469.2M).
Long Term Liabilities: CPCI's short term assets (EGP1.1B) exceed its long term liabilities (EGP213.4M).
Debt to Equity History and Analysis
Debt Level: CPCI's net debt to equity ratio (3.8%) is considered satisfactory.
Reducing Debt: CPCI's debt to equity ratio has increased from 0% to 24% over the past 5 years.
Debt Coverage: CPCI's debt is well covered by operating cash flow (131.4%).
Interest Coverage: CPCI's interest payments on its debt are well covered by EBIT (67x coverage).